DIETHYLPROPION HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Diethylpropion Hydrochloride patents expire, and what generic alternatives are available?
Diethylpropion Hydrochloride is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs. and is included in ten NDAs.
The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diethylpropion Hydrochloride
A generic version of DIETHYLPROPION HYDROCHLORIDE was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
Summary for DIETHYLPROPION HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 10 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Clinical Trials: | 2 |
Patent Applications: | 643 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in DIETHYLPROPION HYDROCHLORIDE? | DIETHYLPROPION HYDROCHLORIDE excipients list |
DailyMed Link: | DIETHYLPROPION HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DIETHYLPROPION HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | |
New River Pharmaceuticals | Phase 1/Phase 2 |
Pharmacology for DIETHYLPROPION HYDROCHLORIDE
Drug Class | Sympathomimetic Amine Anorectic |
Physiological Effect | Appetite Suppression Increased Sympathetic Activity |